External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment

2 September 2024 (12:30 - 12:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mrs Mari Nordboe Gynnild

St. Olav University Hospital, Trondheim (Norway)

4 More presentations in this session

Presentation thumbnail

Predictive value of Type D personality combined with unhealthy cardiovascular behaviors for the long-term adverse cardiovascular events in ACS patients

Mrs Y. Wang (Harbin, CN)

Abstract Slides Video

Presentation thumbnail

Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study

Doctor S. Gauci (Geelong, AU)

Abstract Slides Video

Presentation thumbnail

Insights into the aetiology and temporal trends in cardiac mortality in the young: a 21-year review of national and registry data in the united kingdom

Doctor R. Bhatia (London, GB)

Abstract Slides Video

Presentation thumbnail

Pregnancy complications and long-term risk of cardiovascular events in women with heart disease

Doctor E. Taufer Cederlof (Uppsala, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Mental stress, nutrition, pregnancy, and cancer: risk factors for heart disease

The Event

Event poster

ESC Congress 2024

2 September 2024 12:30 CET

You may be interested in

Congress Presentation

Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease

Congress Presentation

Current challenges in risk stratification of cancer therapy-related cardiovascular toxicity

Congress Presentation

External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources